GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...
The global burden of stroke is considerable, according to a study published in the October issue of The Lancet Neurology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback